What amount sold does Guide Therapeutics, Inc. report in Form D filings?

The latest linked filings report $13.9M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Guide Therapeutics, Inc.'s most recent SEC filing?

Guide Therapeutics, Inc.'s most recent Form D filing was on 2020-08-24.

How many investors does Guide Therapeutics, Inc. have?

The most recent Form D filing lists 3 investor(s).

What type of securities does Guide Therapeutics, Inc. offer?

Guide Therapeutics, Inc.'s SEC Form D filings indicate equity offerings.

Guide Therapeutics, Inc.

CIK: 0001769132·Biotechnology·TUCKER, GA·Corporation·Founded 2018

Reported Sold

$13,862,139

Total Filings

Identified Offerings

Last Filed

Aug 24, 2020

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Aug 24, 2020Form D — New notice

Reported sold: $5,862,139 · Target: $5,862,139

Rule 506(b)·3 investors

Jan 13, 2020Form D/A — Amendment

Reported sold: $8,000,000 · Target: $8,000,000

Rule 506(b)·2 investors

Changed: Reported amount sold, Offering target

Apr 25, 2019Form D/A — Amendment

Reported sold: $6,000,000 · Target: $6,000,000

Rule 506(b)·2 investors

Changed: Reported amount sold, Offering target, Reported investors

Feb 28, 2019Form D — New notice

Reported sold: $2,500,000 · Target: $5,000,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 2 identified offerings

$13,862,139

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

James Dahlman

Related Person

Appears on 2 filings

Thomas Reese Saylor

Related Person

Appears on 2 filings

Andrew Perlman

Related Person

Appears on 2 filings

Julie Sunderland

Related Person

Appears on 2 filings

Andrew Perlman

Related Person

Appears on 2 filings

James Dahlman

Related Person

Appears on 2 filings

Boris Nikolic

Related Person

Appears on 1 filing

Robert Hershberg

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 24, 2020	New	$5,862,139	$5,862,139	3
Jan 13, 2020	Amendment	$8,000,000	$8,000,000	2
Apr 25, 2019	Amendment	$6,000,000	$6,000,000	2
Feb 28, 2019	New	$5,000,000	$2,500,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Ausel, Inc.

Biotechnology

Offering target: $5,000,000

Filed Nov 4, 2026